Market Cap: $21.15B
GI
Guardant Health, Inc.
GH
NASDAQ (NASDAQ Global Select)USD
Market Cap: $21.15B
Guardant Health Prepares for Engaging Investor Conferences Guardant Health, Inc., a leading precision oncology company headquartered in Palo Alto, California, is set to showcase its advancements and i…
Guardant Health Engages Stakeholders Through Upcoming Conferences Guardant Health, Inc., a leading precision oncology company based in Palo Alto, California, actively engages with stakeholders through…
Guardant Health's Strategic Financial Restructuring: A Focus on Convertible Notes Guardant Health, Inc., a leader in precision oncology based in Palo Alto, recently announces a significant financial r…
Guardant Health Partners with Abu Dhabi to Enhance Colorectal Cancer Screening Guardant Health, Inc., a leader in precision oncology, forges a significant partnership with the Abu Dhabi Public Health…
Revolutionizing Colorectal Cancer Screening in Abu Dhabi with Guardant Health's Shield™ Test Guardant Health, Inc. has forged a strategic partnership with the Abu Dhabi Public Health Center (ADPHC) to…
Guardant Health Showcases Innovations in Precision Oncology at ASCO GI Symposium Guardant Health, Inc., a leading player in precision oncology, prepares to present groundbreaking data at the upcoming…
Guardant Health Showcases Innovations in Precision Oncology at ASCO GI Symposium Guardant Health, Inc., a leader in precision oncology based in Palo Alto, California, focuses on advancing cancer care…
Guardant Health and ConcertAI Unite to Transform Precision Oncology Guardant Health, a leader in precision oncology, announces a strategic partnership with ConcertAI, a notable provider of oncology re…
Transforming Lung Cancer Care Through AI Collaboration In a strategic move aimed at enhancing lung cancer treatment, Viz.ai, a leader in AI-powered disease detection, announces a proposed collaboratio…
Guardant Health Reports Significant Growth in Precision Oncology Services Guardant Health, Inc., a leading precision oncology company headquartered in Palo Alto, California, showcases promising growth…
Guardant Health's Significant Growth in Precision Oncology Services Guardant Health, a leader in precision oncology based in Palo Alto, California, showcases a notable surge in its operational metrics…
Guardant Health Joins NCI’s Vanguard Study to Enhance Multi-Cancer Detection Guardant Health, Inc. is selected by the National Cancer Institute (NCI) to participate in its Vanguard study, a significan…
Guardant Health to Showcase Innovative Cancer Solutions at J.P. Morgan Healthcare Conference Guardant Health, a leading precision oncology company, prepares to present its groundbreaking advancements…
Guardant Health Showcases Innovations at J.P. Morgan Healthcare Conference Guardant Health, Inc., a leading precision oncology company headquartered in Palo Alto, California, prepares for its particip…
Guardant Health Partners with MiBA to Enhance Precision Oncology Guardant Health, Inc., a leader in precision oncology, has announced a strategic partnership with Meaningful Insights Biotech Analytics…
Guardant Health Partners with Boehringer Ingelheim to Enhance Lung Cancer Treatment Guardant Health, Inc., a leading precision oncology firm based in Palo Alto, California, announces a strategic colla…
Guardant Health Showcases Precision Oncology Innovations at SABCS 2024 Guardant Health, a leader in precision oncology based in Palo Alto, California, is set to present a range of significant advancem…
Guardant Health Advances Precision Oncology at SABCS 2024 Guardant Health, Inc., a leading name in precision oncology based in Palo Alto, California, prepares to unveil its latest innovations at the S…
Guardant Health: Pioneering Advances in Liquid Biopsy Technology Guardant Health is at the forefront of revolutionizing cancer detection and management through its innovative liquid biopsy technology.…
Guardant Health Advances in Liquid Biopsy Innovations Guardant Health (GH), a leader in precision oncology, continues to solidify its position within the liquid biopsy market, which is gaining tractio…
Guardant Health Strengthens Workforce with New Equity Awards On October 22, 2024, Guardant Health, Inc., a leader in precision oncology, announces a strategic move to enhance its workforce by approvin…
Guardant Health’s Strategic Engagement in Healthcare Innovation Conferences Guardant Health, a leading precision oncology company headquartered in Palo Alto, California, actively participates in the u…
Guardant Health Highlights Colorectal Cancer Screening Innovations at ACG 2024 Guardant Health, Inc., a leading precision oncology company based in Palo Alto, California, is set to present crucial fin…